{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:43Z","timestamp":1792784263410,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030312009"],"award-info":[{"award-number":["2017A030312009"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313111"],"award-info":[{"award-number":["2017A030313111"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071386"],"award-info":[{"award-number":["82071386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974329"],"award-info":[{"award-number":["81974329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672140"],"award-info":[{"award-number":["81672140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory","award":["2018GZR110104008"],"award-info":[{"award-number":["2018GZR110104008"]}],"id":[{"id":"https:\/\/ror.org\/01n179w26","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Grant of Guangdong Province Key Laboratory of Psychiatric Disorders","award":["N201904"],"award-info":[{"award-number":["N201904"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12035-022-03041-9","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:03:57Z","timestamp":1665403437000},"page":"51-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Perlecan Improves Blood Spinal Cord Barrier Repair Through the Integrin \u03b21\/ROCK\/MLC Pathway After Spinal Cord Injury"],"prefix":"10.1007","volume":"60","author":[{"given":"Changnan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-2903","authenticated-orcid":false,"given":"Jiasong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3055-3063","authenticated-orcid":false,"given":"Lixin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"1","key":"3041_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/stem.3097","volume":"38","author":"W Xue","year":"2020","unstructured":"Xue W et al (2020) Epidermal growth factor receptor-extracellular-regulated kinase blockade upregulates TRIM32 signaling cascade and promotes neurogenesis after spinal cord injury. Stem Cells 38(1):118\u2013133","journal-title":"Stem Cells"},{"issue":"5","key":"3041_CR2","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1007\/s12035-016-9910-6","volume":"54","author":"H Kumar","year":"2017","unstructured":"Kumar H et al (2017) Propitious therapeutic modulators to prevent blood-spinal cord barrier disruption in spinal cord injury. Mol Neurobiol 54(5):3578\u20133590","journal-title":"Mol Neurobiol"},{"issue":"7705","key":"3041_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-018-0068-4","volume":"557","author":"MV Sofroniew","year":"2018","unstructured":"Sofroniew MV (2018) Dissecting spinal cord regeneration. Nature 557(7705):343\u2013350","journal-title":"Nature"},{"key":"3041_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2016.06.018","volume":"158","author":"J Hu","year":"2016","unstructured":"Hu J et al (2016) Targeting the blood-spinal cord barrier: a therapeutic approach to spinal cord protection against ischemia-reperfusion injury. Life Sci 158:1\u20136","journal-title":"Life Sci"},{"issue":"10","key":"3041_CR5","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1083\/jcb.201807178","volume":"218","author":"K Nakamura","year":"2019","unstructured":"Nakamura K et al (2019) Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. J Cell Biol 218(10):3506\u20133525","journal-title":"J Cell Biol"},{"issue":"10","key":"3041_CR6","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1177\/0271678X17722436","volume":"37","author":"MS Thomsen","year":"2017","unstructured":"Thomsen MS, Routhe LJ, Moos T (2017) The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab 37(10):3300\u20133317","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"3041_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1089\/neu.2009.1111","volume":"27","author":"T Takigawa","year":"2010","unstructured":"Takigawa T et al (2010) Separation of the perivascular basement membrane provides a conduit for inflammatory cells in a mouse spinal cord injury model. J Neurotrauma 27(4):739\u2013751","journal-title":"J Neurotrauma"},{"key":"3041_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fphar.2012.00155","volume":"3","author":"J Roberts","year":"2012","unstructured":"Roberts J, Kahle MP, Bix GJ (2012) Perlecan and the blood-brain barrier: beneficial proteolysis? Front Pharmacol 3:155","journal-title":"Front Pharmacol"},{"issue":"4","key":"3041_CR9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.STR.0000119383.76447.05","volume":"35","author":"S Fukuda","year":"2004","unstructured":"Fukuda S et al (2004) Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35(4):998\u20131004","journal-title":"Stroke"},{"issue":"2","key":"3041_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.scr.2013.12.009","volume":"12","author":"A Kerever","year":"2014","unstructured":"Kerever A et al (2014) Perlecan is required for FGF-2 signaling in the neural stem cell niche. Stem Cell Res 12(2):492\u2013505","journal-title":"Stem Cell Res"},{"issue":"11","key":"3041_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/genes9110556","volume":"9","author":"JR Martinez","year":"2018","unstructured":"Martinez JR, Dhawan A, Farach-Carson MC (2018) Modular proteoglycan Perlecan\/HSPG2: mutations, phenotypes, and functions. Genes (Basel) 9(11):556","journal-title":"Genes (Basel)"},{"issue":"2","key":"3041_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/svn-2018-000198","volume":"4","author":"L Xu","year":"2019","unstructured":"Xu L, Nirwane A, Yao Y (2019) Basement membrane and blood-brain barrier. Stroke Vasc Neurol 4(2):78\u201382","journal-title":"Stroke Vasc Neurol"},{"issue":"8","key":"3041_CR13","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1172\/JCI46358","volume":"121","author":"B Lee","year":"2011","unstructured":"Lee B et al (2011) Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest 121(8):3005\u20133023","journal-title":"J Clin Invest"},{"issue":"10","key":"3041_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/WNR.0b013e3283554c5c","volume":"23","author":"MP Kahle","year":"2012","unstructured":"Kahle MP et al (2012) Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue. NeuroReport 23(10):627\u2013630","journal-title":"NeuroReport"},{"issue":"1","key":"3041_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12975-020-00800-5","volume":"12","author":"AL Trout","year":"2021","unstructured":"Trout AL et al (2021) Perlecan domain-V enhances neurogenic brain repair after stroke in mice. Transl Stroke Res 12(1):72\u201386","journal-title":"Transl Stroke Res"},{"issue":"6","key":"3041_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s004010100414","volume":"102","author":"J van Horssen","year":"2001","unstructured":"van Horssen J et al (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer\u2019s disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol 102(6):604\u2013614","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3041_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneumeth.2008.10.015","volume":"177","author":"SA Marques","year":"2009","unstructured":"Marques SA et al (2009) A simple, inexpensive and easily reproducible model of spinal cord injury in mice: morphological and functional assessment. J Neurosci Methods 177(1):183\u2013193","journal-title":"J Neurosci Methods"},{"issue":"13","key":"3041_CR18","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1523\/JNEUROSCI.2229-19.2020","volume":"40","author":"C Xie","year":"2020","unstructured":"Xie C et al (2020) Astrocytic YAP promotes the formation of glia scars and neural regeneration after spinal cord injury. J Neurosci 40(13):2644\u20132662","journal-title":"J Neurosci"},{"issue":"2","key":"3041_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1089\/08977150252806947","volume":"19","author":"M Joshi","year":"2002","unstructured":"Joshi M, Fehlings MG (2002) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 19(2):175\u201390","journal-title":"J Neurotrauma"},{"issue":"1","key":"3041_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-021-01059-5","volume":"14","author":"L Yang","year":"2021","unstructured":"Yang L et al (2021) Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN. J Hematol Oncol 14(1):46","journal-title":"J Hematol Oncol"},{"issue":"7536","key":"3041_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S et al (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517(7536):583\u2013588","journal-title":"Nature"},{"issue":"5","key":"3041_CR22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/STROKEAHA.115.011552","volume":"47","author":"J Wu","year":"2016","unstructured":"Wu J et al (2016) Recombinant osteopontin stabilizes smooth muscle cell phenotype via integrin receptor\/integrin-linked kinase\/Rac-1 pathway after subarachnoid hemorrhage in rats. Stroke 47(5):1319\u20131327","journal-title":"Stroke"},{"issue":"8","key":"3041_CR23","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/STROKEAHA.110.586537","volume":"41","author":"H Suzuki","year":"2010","unstructured":"Suzuki H et al (2010) Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke 41(8):1783\u20131790","journal-title":"Stroke"},{"key":"3041_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bbi.2019.04.016","volume":"80","author":"Y Gu","year":"2019","unstructured":"Gu Y et al (2019) Conditional ablation of reactive astrocytes to dissect their roles in spinal cord injury and repair. Brain Behav Immun 80:394\u2013405","journal-title":"Brain Behav Immun"},{"issue":"4","key":"3041_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nm1007","volume":"10","author":"D Demjen","year":"2004","unstructured":"Demjen D et al (2004) Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med 10(4):389\u2013395","journal-title":"Nat Med"},{"key":"3041_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbr.2015.05.004","volume":"291","author":"N Xu","year":"2015","unstructured":"Xu N et al (2015) A sensitive and reliable test instrument to assess swimming in rats with spinal cord injury. Behav Brain Res 291:172\u2013183","journal-title":"Behav Brain Res"},{"issue":"2","key":"3041_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/exnr.2001.7679","volume":"169","author":"M Ma","year":"2001","unstructured":"Ma M et al (2001) Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl\/6 mouse. Exp Neurol 169(2):239\u2013254","journal-title":"Exp Neurol"},{"issue":"1","key":"3041_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.2008.0543","volume":"26","author":"RL Hill","year":"2009","unstructured":"Hill RL et al (2009) Anatomical and functional outcomes following a precise, graded, dorsal laceration spinal cord injury in C57BL\/6 mice. J Neurotrauma 26(1):1\u201315","journal-title":"J Neurotrauma"},{"key":"3041_CR29","doi-asserted-by":"publisher","first-page":"101932","DOI":"10.1016\/j.redox.2021.101932","volume":"41","author":"X Ge","year":"2021","unstructured":"Ge X et al (2021) Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-\u03baB signaling pathway in vascular endothelial cells after traumatic spinal cord injury. Redox Biol 41:101932","journal-title":"Redox Biol"},{"issue":"6","key":"3041_CR30","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1007\/s12035-020-01914-5","volume":"57","author":"HP Joshi","year":"2020","unstructured":"Joshi HP et al (2020) CORM-2-solid lipid nanoparticles maintain integrity of blood-spinal cord barrier after spinal cord injury in rats. Mol Neurobiol 57(6):2671\u20132689","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3041_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12987-020-00232-1","volume":"17","author":"X Ying","year":"2020","unstructured":"Ying X et al (2020) Water treadmill training attenuates blood-spinal cord barrier disruption in rats by promoting angiogenesis and inhibiting matrix metalloproteinase-2\/9 expression following spinal cord injury. Fluids Barriers CNS 17(1):70","journal-title":"Fluids Barriers CNS"},{"key":"3041_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fnana.2017.00136","volume":"11","author":"J Xu","year":"2017","unstructured":"Xu J et al (2017) Ultrastructural features of neurovascular units in a rat model of chronic compressive spinal cord injury. Front Neuroanat 11:136","journal-title":"Front Neuroanat"},{"issue":"13","key":"3041_CR33","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1523\/JNEUROSCI.2841-16.2017","volume":"37","author":"CM Freria","year":"2017","unstructured":"Freria CM et al (2017) Deletion of the fractalkine receptor, CX3CR1, improves endogenous repair, axon sprouting, and synaptogenesis after spinal cord injury in mice. J Neurosci 37(13):3568\u20133587","journal-title":"J Neurosci"},{"issue":"1","key":"3041_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0271678X18801467","volume":"39","author":"Y Yao","year":"2019","unstructured":"Yao Y (2019) Basement membrane and stroke. J Cereb Blood Flow Metab 39(1):3\u201319","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"3041_CR35","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/nm1505","volume":"12","author":"S Kaneko","year":"2006","unstructured":"Kaneko S et al (2006) A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 12(12):1380\u20131389","journal-title":"Nat Med"},{"issue":"1","key":"3041_CR36","first-page":"52","volume":"23","author":"ZW Ren","year":"2019","unstructured":"Ren ZW et al (2019) Effect of exosomes derived from MiR-133b-modified ADSCs on the recovery of neurological function after SCI. Eur Rev Med Pharmacol Sci 23(1):52\u201360","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"3041_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s13311-018-0631-6","volume":"15","author":"MB Orr","year":"2018","unstructured":"Orr MB, Gensel JC (2018) Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics 15(3):541\u2013553","journal-title":"Neurotherapeutics"},{"issue":"2","key":"3041_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.22421","volume":"70","author":"V Bartanusz","year":"2011","unstructured":"Bartanusz V et al (2011) The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol 70(2):194\u2013206","journal-title":"Ann Neurol"},{"issue":"1","key":"3041_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00424-016-1920-8","volume":"469","author":"AK Reinhold","year":"2017","unstructured":"Reinhold AK, Rittner HL (2017) Barrier function in the peripheral and central nervous system-a review. Pflugers Arch 469(1):123\u2013134","journal-title":"Pflugers Arch"},{"issue":"7","key":"3041_CR40","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3390\/ijms20071594","volume":"20","author":"S Nag","year":"2019","unstructured":"Nag S et al (2019) Increased Expression of vascular endothelial growth factor-D following brain injury. Int J Mol Sci 20(7):1594","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3041_CR41","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/01.LAB.0000082383.40635.FE","volume":"83","author":"N Nourhaghighi","year":"2003","unstructured":"Nourhaghighi N et al (2003) Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest 83(8):1211\u20131222","journal-title":"Lab Invest"},{"issue":"1","key":"3041_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mvr.2008.09.012","volume":"77","author":"N Prasain","year":"2009","unstructured":"Prasain N, Stevens T (2009) The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 77(1):53\u201363","journal-title":"Microvasc Res"},{"key":"3041_CR43","doi-asserted-by":"publisher","first-page":"10523","DOI":"10.1038\/ncomms10523","volume":"7","author":"Y Shi","year":"2016","unstructured":"Shi Y et al (2016) Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat Commun 7:10523","journal-title":"Nat Commun"},{"issue":"2","key":"3041_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1152\/physrev.00026.2002","volume":"83","author":"CG dos Remedios","year":"2003","unstructured":"dos Remedios CG et al (2003) Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 83(2):433\u2013473","journal-title":"Physiol Rev"},{"issue":"11","key":"3041_CR45","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/dneu.20954","volume":"71","author":"KM Baeten","year":"2011","unstructured":"Baeten KM, Akassoglou K (2011) Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol 71(11):1018\u20131039","journal-title":"Dev Neurobiol"},{"issue":"10","key":"3041_CR46","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/jcbfm.2011.98","volume":"31","author":"B Engelhardt","year":"2011","unstructured":"Engelhardt B (2011) \u03b21-integrin\/matrix interactions support blood-brain barrier integrity. J Cereb Blood Flow Metab 31(10):1969\u20131971","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"3041_CR47","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0271678X17722108","volume":"38","author":"Y Izawa","year":"2018","unstructured":"Izawa Y et al (2018) \u03b21-integrin-matrix interactions modulate cerebral microvessel endothelial cell tight junction expression and permeability. J Cereb Blood Flow Metab 38(4):641\u2013658","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"3041_CR48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1046\/j.1471-4159.2002.01129.x","volume":"83","author":"Y Deguchi","year":"2002","unstructured":"Deguchi Y et al (2002) Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan. J Neurochem 83(2):381\u2013389","journal-title":"J Neurochem"},{"issue":"2","key":"3041_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1136(199710)21:2<228::AID-GLIA6>3.0.CO;2-2","volume":"21","author":"JD Miller","year":"1997","unstructured":"Miller JD et al (1997) Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia\/macrophages following infusion of beta-amyloid protein into rodent hippocampus. Glia 21(2):228\u2013243","journal-title":"Glia"},{"key":"3041_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.matbio.2014.04.005","volume":"36","author":"BJ Grindel","year":"2014","unstructured":"Grindel BJ et al (2014) Matrilysin\/matrix metalloproteinase-7(MMP7) cleavage of perlecan\/HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biol 36:64\u201376","journal-title":"Matrix Biol"},{"issue":"5","key":"3041_CR51","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12975-013-0266-1","volume":"4","author":"GJ Bix","year":"2013","unstructured":"Bix GJ, Gowing EK, Clarkson AN (2013) Perlecan domain V is neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice. Transl Stroke Res 4(5):515\u2013523","journal-title":"Transl Stroke Res"},{"issue":"1","key":"3041_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-014-9576-6","volume":"30","author":"A Marcelo","year":"2015","unstructured":"Marcelo A, Bix G (2015) The potential role of perlecan domain V as novel therapy in vascular dementia. Metab Brain Dis 30(1):1\u20135","journal-title":"Metab Brain Dis"},{"issue":"Pt 3","key":"3041_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1242\/jcs.006064","volume":"121","author":"WP Daley","year":"2008","unstructured":"Daley WP, Peters SB, Larsen M (2008) Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121(Pt 3):255\u2013264","journal-title":"J Cell Sci"},{"issue":"7811","key":"3041_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-020-2264-2","volume":"582","author":"C Kyprianou","year":"2020","unstructured":"Kyprianou C et al (2020) Basement membrane remodelling regulates mouse embryogenesis. Nature 582(7811):253\u2013258","journal-title":"Nature"},{"key":"3041_CR55","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2741\/1883","volume":"11","author":"Y Gasche","year":"2006","unstructured":"Gasche Y et al (2006) Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 11:1289\u20131301","journal-title":"Front Biosci"},{"issue":"18","key":"3041_CR56","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1523\/JNEUROSCI.0498-17.2017","volume":"37","author":"R Rust","year":"2017","unstructured":"Rust R, Kaiser J (2017) Insights into the dual role of inflammation after spinal cord injury. J Neurosci 37(18):4658\u20134660","journal-title":"J Neurosci"},{"issue":"7","key":"3041_CR57","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/cns.12405","volume":"21","author":"WY Liu","year":"2015","unstructured":"Liu WY et al (2015) Increasing the permeability of the blood-brain barrier in three different models in vivo. CNS Neurosci Ther 21(7):568\u2013574","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"3041_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.devcel.2009.01.004","volume":"16","author":"E Dejana","year":"2009","unstructured":"Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16(2):209\u2013221","journal-title":"Dev Cell"},{"issue":"3","key":"3041_CR59","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/brv.12398","volume":"93","author":"B Nieuwenhuis","year":"2018","unstructured":"Nieuwenhuis B et al (2018) Integrins promote axonal regeneration after injury of the nervous system. Biol Rev Camb Philos Soc 93(3):1339\u20131362","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"6","key":"3041_CR60","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.apsb.2020.02.015","volume":"10","author":"J Tang","year":"2020","unstructured":"Tang J et al (2020) TIMP1 preserves the blood-brain barrier through interacting with CD63\/integrin \u03b2 1 complex and regulating downstream FAK\/RhoA signaling. Acta Pharm Sin B 10(6):987\u20131003","journal-title":"Acta Pharm Sin B"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03041-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-03041-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03041-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T23:35:00Z","timestamp":1671233700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-03041-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3041"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-03041-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with Institutional Animal Care and Use committee guidelines and approved protocols at the Southern Medical University (ethics Number: LAEC-2022\u2013064).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All data generated or analyzed during this study are included in this published article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}